ARIA Ariad Pharmaceuticals Inc. - ARIA
penny stocks
+ Reply to Thread
Results 1 to 8 of 8
  1. #1
    Join Date
    Aug 2008
    Posts
    1,428

    Default Ariad Pharmaceuticals Inc. - ARIA

    Chart has a huge bullish candle today (what doesnt on a 900+ point upward move from the dow )

    Resistance at 2.32 and 2.81 ahead with support at 1.40 we must hold over imo

    All my signatures are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

  2. #2
    Join Date
    Aug 2008
    Posts
    1,428

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    Finally it looks like ARIA Ariad Pharmaceuticals Inc. has started to form a bottom, a break of 1.40 would be key here.

    Quote Originally Posted by Stock_Analyzer View Post
    Chart has a huge bullish candle today (what doesnt on a 900+ point upward move from the dow )

    Resistance at 2.32 and 2.81 ahead with support at 1.40 we must hold over imo

    All my signatures are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

  3. #3
    Join Date
    Aug 2008
    Posts
    1,428

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    Ariad Pharmaceuticals Inc. - ARIA A perfect swing trade lately from about 1.15 to 1.30 or so, still a break of 1.40 could get the stock started upward more.


    All my signatures are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here

  4. #4
    Join Date
    Nov 2008
    Posts
    279

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    ARIAD Pharmaceuticals Inc. (ARIA)
    Sector Healthcare - Industry Biotechnology - Exchange NAS

    Short Interest (Shares Short) 5,329,700
    Days To Cover (Short Interest Ratio) 16.1
    Short Percent of Float 8.73 %
    Short Interest - Prior 5,445,900
    Short % Increase / Decrease -2.13 %
    Short Squeeze Ranking™ -102

    % From 52-Wk High ($ 4.56 ) -242.86 %
    % From 52-Wk Low ($ 1.09 ) 18.05 %
    % From 200-Day MA ($ 2.36 ) -77.44 %
    % From 50-Day MA ($ 1.52 ) -14.29 %
    Price % Change (52-Week) -72.50 %

    Shares Float 61,020,000
    Total Shares Outstanding 69,476,467
    % Owned by Insiders 3.93 %
    % Owned by Institutions 56.80 %
    Market Cap. $ 92,403,701
    Trading Volume - Today 912,395
    Trading Volume - Average 331,200
    Trading Volume - Today vs. Average 275.48 %
    Earnings Per Share -0.89
    PE Ratio
    Record Date 2008-DecA

    Dividend -
    Employees 116
    Optionable Yes
    Shortable No
    Beta 1,50
    Volatility 15.13% 14.48%
    Perf Week 3.10%
    Perf Month -4.32%
    Perf Quarter -53.50%
    Perf Half Y -49.04%
    Perf Year -69.91%
    Perf YTD -68.71%

    Target Price from Analyst Recommendation :
    16-Oct-08 Initiated Merriman Curhan Ford Neutral
    02-Jun-08 Reiterated Canaccord Adams Hold $5.20 → $3.50
    14-Dec-07 Initiated Jefferies & Co Buy $8
    28-Nov-07 Downgrade JP Morgan Overweight → Neutral
    13-Jul-07 Downgrade Canaccord Adams Buy → Hold $6
    12-Jul-07 Reiterated Lazard Capital Buy $9 → $11
    09-Apr-07 Reiterated Lehman Brothers Overweight $16 → $7
    16-Feb-07 Reiterated Lazard Capital Buy $11 → $9
    12-Feb-07 Upgrade JP Morgan Neutral → Overweight

    Summary
    ARIAD Pharmaceuticals, Inc. is engaged in the discovery and development of medicines to treat cancers by regulating cell signaling with small molecules. The Company is developing an approach to patients with cancer that addresses aggressive and advanced-stage cancers. Its lead cancer product candidate, deforolimus (previously known as AP23573), is an internally discovered, potent inhibitor of the protein mTOR. Deforolimus was discovered in a research and development program conducted on behalf of ARIAD Gene Therapeutics, Inc., an 80%-owned subsidiary. AP24534, the second product candidate, is a multi-targeted kinase inhibitor believed to have potential applications in cancer, including various forms of leukemia. ARIAD Pharmaceuticals also has a focused drug discovery program centered on small-molecule therapies, molecularly targeted to cell-signaling pathways implicated in cancer.

    Adress
    26 Landsdowne Street
    Cambridge, MA 02139
    United States - Map
    +1-617-4940400 (Phone)
    +1-617-4948144 (Fax)
    Company website:
    Leading the Pathway to Better Cancer Therapies - ARIAD

    Looking for a specific market listing? Select from the list below:
    Symbol Company Name Prime Exchange
    Symbol Company Name Prime Exchange
    ARIA.W Ariad Pharmaceuticals Inc NASD ADF
    ARIA.OQ Ariad Pharmaceuticals Inc NASDAQ Stock Exchange Global Market
    ARIA.DE Ariad Pharmaceuticals Inc Xetra
    ARIA.O Ariad Pharmaceuticals Inc Consolidated Issue listed on NASDAQ Global Market
    ARIA.DF Ariad Pharmaceuticals Inc NASD ADF
    ARIA.BE Ariad Pharmaceuticals Inc Berlin Stock Exchange
    ARIA.F Ariad Pharmaceuticals Inc Frankfurt Stock Exchange
    ARIA.C Ariad Pharmaceuticals Inc Cincinatti Stock Exchange
    ARIA.P Ariad Pharmaceuticals Inc NYSE Arca
    ARIA.MU Ariad Pharmaceuticals Inc Munich Stock Exchange
    ARIA.D Ariad Pharmaceuticals Inc Dusseldorf Stock Exchange
    ARIA.PH Ariad Pharmaceuticals Inc Philadelphia Stock Exchange
    ARIA.MW Ariad Pharmaceuticals Inc Midwest Stock Exchange

  5. #5
    Join Date
    Dec 2008
    Posts
    17

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    I thought this stock had hit the bottom. Looks like it fell again. What is going on with this thing?

    I wanna see this one back in at least the $2 range.

  6. #6
    Join Date
    Dec 2008
    Posts
    17

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    After the FEDs cut the interest rated we spiked back to the daily high. still, i'd like to see this one back up in the $2 range.

  7. #7
    Join Date
    Dec 2008
    Posts
    17

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    Amyone got anything on this stock?

  8. #8
    Join Date
    Dec 2008
    Posts
    17

    Default Re: Ariad Pharmaceuticals Inc. - ARIA

    back over 1.20. volume is starting to pick up, looking good.

Checking For Related Data...

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

     

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
 
© StockHideout.com - All rights reserved. penny stocks, stock message board
Web Analytics